Palomino Laboratories Inc.

Blank Checks

ipo priced 424B3

Filing Timeline

SEC EDGAR

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows EFFECT and confirms the priced prospectus.

16,083,036 shares

Common Stock · Units sold in private placement at $1.50 per unit (6,504,017 shares) and $1.20 per unit (1,537,501 shares) · Warrants exercisable at $1.50 per share (8,041,518 shares) · Selling stockholders only · Use of proceeds Selling stockholders will sell shares, no issuer proceeds

Palomino Laboratories Inc. is a fabless semiconductor company developing microLED-based optoelectronic solutions for high-speed data communication. The filing relates to a resale offering of 16,083,036 shares of common stock by selling stockholders, including shares from private placements, SAFE conversions, and warrant exercises. The company is not receiving proceeds from the offering and aims to list on OTC Markets, though no market maker is currently committed. The filing highlights risks related to lack of liquidity, supply chain dependencies, and trade policy uncertainties.

2026-02-12 · 0001493152-26-006261

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows S-1 and marks the registration effective.

Palomino Laboratories Inc. has received SEC approval for its S-1 registration statement, indicating the filing became effective on February 9, 2026. The document primarily contains technical metadata and financial reporting tags without substantive updates or disclosures beyond the effectiveness notice.

2026-02-09 · 9999999995-26-000481

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

Follows DRS in the pre-IPO sequence.

Palomino Laboratories Inc. has filed an S-1 registration statement for an initial public offering (IPO), disclosing plans to offer up to 16,083,036 shares of common stock. The filing includes details about private placements, warrants, and potential resale by selling stockholders. The company aims to list on the OTCQB after the registration becomes effective, though no market maker has committed to quoting its shares yet.

2026-01-23 · 0001493152-26-003287

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

First tracked pre-IPO filing for this issuer.

Palomino Laboratories Inc. is a fabless semiconductor company developing high-performance microLED-based optoelectronic solutions for data communication. The company is undergoing a public offering of up to 16,083,036 shares of common stock, sourced from private placements and convertible instruments. Palomino recently completed a merger with Unite Acquisition 3 Corp.'s subsidiary, transitioning from a shell company to a public reporting entity. The offering is structured through selling stockholders, with no direct proceeds to the company. Palomino aims to enable ultra-high-speed optical interconnects for AI servers and data centers using proprietary gallium nitride (GaN) technology.

2026-01-12 · 0001493152-26-001169

Comparable Deals

Not enough completed IPOs with similar characteristics to show comparables yet.

Recent News

No recent news stored for this issuer.